Current sequence databases now contain numerous whole genome sequences of pathogenic bacteria. However, many of the predicted genes lack any functional annotation. We describe an assumptionfree approach, Rapid Virulence Annotation (RVA), for the highthroughput parallel screening of genomic libraries against four different taxa: insects, nematodes, amoeba, and mammalian macrophages. These hosts represent different aspects of both the vertebrate and invertebrate immune system. Here, we apply RVA to the emerging human pathogen Photorhabdus asymbiotica using ''gain of toxicity'' assays of recombinant Escherichia coli clones. We describe a wealth of potential virulence loci and attribute biological function to several putative genomic islands, which may then be further characterized using conventional molecular techniques. The application of RVA to other pathogen genomes promises to ascribe biological function to otherwise uncharacterized virulence genes.
bacteria ͉ pathogenomics ͉ screening ͉ toxins ͉ entomopathogenic T he growing speed with which the genomes of bacteria can be sequenced is producing an ever expanding knowledge gap between sequence data and its functional annotation. In the case of bacterial pathogens, the identification of virulence factors has typically relied on genetic knock-out and demonstration that virulence is attenuated in a suitable animal model. This approach is not only time consuming and expensive but also, in the case of the use of vertebrate models, ethically debatable. Here, we demonstrate the power of using parallel screens for the identification of virulence genes using three invertebrate infection models and mammalian macrophages in tissue culture, collectively termed Rapid Virulence Annotation (RVA). RVA utility relies upon similarities between the immune responses of vertebrates and invertebrates. The innate immune systems of insects and mammals share many common features, both mechanistically and genetically (1, 2) . In addition, much of the basic cellular machinery and pathways that bacterial pathogens can subvert during infection is also well conserved among eukaryotes, presenting common targets. This suggests that virulence mechanisms used by pathogens of mammals may work against invertebrates and vice versa. Indeed, we suggest many virulence strategies evolved initially to combat invertebrates have subsequently been redeployed against vertebrates (3) . To test these predictions, we conducted an RVA-based screen on a recently emerging pathogen, Photorhabdus asymbiotica, which is a pathogen of both insects and man (4) and causes invasive soft tissue and disseminated bacteraemic infections (5, 6) . Photorhabdus are members of the Enterobacteriaceae that live in association with soil dwelling entomopathogenic Heterorhabditid nematodes and that invade and kill insects. Infective juvenile nematodes seek out and penetrate the insect prey, regurgitating a small number of Photorhabdus cells that evade the immune system, kill the insect, and then bio-convert the tissues into more bacteria. The worm feeds off the bacteria and reproduces until the insect resource is exhausted, whereupon they repackage the bacteria and leave in search of new prey (7) . The requirement to overcome the insect immune system and to keep the insect cadaver free of saprophytic organisms in the soil means that all Photorhabdus produce a range of bioactive molecules including immune inhibitors, toxins, and powerful antimicrobials. The fully annotated genome sequence of the insect-only pathogen Photorhabdus luminescens strain TT01 is available (8) and the genome sequence of the clinical isolate Photorhabdus asymbiotica ATCC43949 is almost completed (http://www.sanger.ac.uk/ Projects/Pasymbiotica/). The availability of the two genomes allows us to correlate the RVA data with regions unique to the human pathogenic P. asymbiotica.
For RVA analysis we sheared the P. asymbiotica ATCC43949 genome and cloned it into recombinant Escherichia coli. The library, covering 91.4% of the estimated 5.0 Mb genome with an average insert size of 37 kb, was arrayed into 16 96-well plates. All 1,536 clones were sequenced at both ends and end-sequences were assembled onto the genomic scaffold. This cosmid library was screened for gain of toxicity (GOT) assays against the nematode Caenorhabditis elegans (nGOT), serving as an oral route model; the single-cell protozoa Acanthamoeba polyphaga (aGOT), used as a phagocytosis model; and two caterpillar models (iGOT), the Tobacco hornworm Manduca sexta and the Waxmoth Galleria mellonella, both of which represent the more complex insect immune systems. Numerous examples of the use of invertebrates as model hosts can be found in the literature (1, (9) (10) (11) (12) . Finally, we used the mouse BALB/c macrophage cell line J774-2 (mGOT) to represent the phagocytic component of the vertebrate immune system. The use of GOT studies in E. coli, in which the model host is challenged with individual clones, has the advantage over chromosomal mutagenesis of ''unmasking'' any virulence factors that would otherwise be hidden due to toxin redundancy or the presence of potent dominant toxins. To define the virulence-related regions (RVA regions), the end sequences of cosmids showing an effect were assembled onto a genomic scaffold and regions of minimum genetic overlap within these clusters were identified, often leading to the identification of specific candidate ORFs or operons. Cross-comparison of genomic regions identified in different assays also gives us an indication of the specificity of the virulence factors identified.
Results
The application of RVA to P. asymbiotica gave a high detection rate of candidate gene clusters, encoding virulence factors, which is a reflection of both the sensitivity of RVA method and also the high level of redundancy in encoded pathogenesis factors in Photorhabdus bacteria (7, 8, 13) . The RVA regions were aligned against the current assembly of the P. asymbiotica genome (Fig.  1) , each region representing a cluster of cosmids identified either in a single screen (with a minimum of two overlapping cosmids) or via a number of parallel screens in combination (Fig. 2) . The complete RVA dataset and more detailed diagrammatic summaries of the 21 RVA regions identified are presented in Table  1 Re-Identification of Known Virulence Factors. The effectiveness of RVA is confirmed by the reidentification of previously known virulence factors, also providing an excellent ''internal'' positive control. Thus, as anticipated, RVA detected mcf1 (RVA20) that encodes a dominant insecticidal toxin (14) and also the phagerelated toxin delivery system PVCpnf (RVA21) (15) . Some cosmids containing part or the full PVCpnf cluster, detected in iGOT, aGOT, and mGOT assays, also contain a hemagglutininlike gene. However, one iGOT cosmid (Fig. S22 ) carries a complete copy of PVCpnf along with a truncated nonribosomal peptide synthase (NRPS), indicating that PVCpnf alone exhibits toxicity to insects as previously demonstrated (15) . Cosmids containing mcf1 were identified in all types of parallel screens, consistent with the ability of Mcf1 to cause apoptosis in both insect and mammalian tissues (16) . Fig. 2 illustrates how a detailed examination of the cosmid locations relative to the genome can reveal the contribution of different gene clusters to toxicity. In several of the mcf1-containing cosmids, the further involvement of tightly linked upstream and downstream NRPS genes in the nGOT and iGOT screens could not be ruled out. Conversely, several cosmids were identified in the mGOT and aGOT assays, which contained only intact mcf1 and one cosmid from each assay that contained only the downstream NRPS cluster. Cosmid 3AG4, carrying only mcf1 (identified by aGOT), was tested against the other models resulting in toxic phenotypes, severe feeding delay in the nematodes, insect death at 24 h, and an exhibition of the typical ''floppy'' phenotype consistent with intoxication by Mcf1 (14) .
Identification of Virulence Factor Homologues. Further confidence in RVA comes from the detection of homologues of virulence factors from other organisms. A ''type VI'' virulence secretion system described in Vibrio cholerae V52 is proposed to provide a target for vaccines and therapeutic agents (17) . The P. asymbiotica RVA screen identified a highly homologous gene cluster (RVA11) detected in the iGOT assay that is 46-90% similar at the predicted amino acid level (Figs. S12 and S23). Indeed, subsequent work has confirmed the importance of a homologous operon in Burkholderia mallei (18) . Interestingly, cosmids toxic to macrophages (mGOT) also span an adjacent region that contains the putative vgrG toxin unique to the human pathogen P. asymbiotica and absent from P. luminescens, potentially representing a genomic island specialized for mammalian pathogenicity. Further, an RVA region showing activity in all assays (locus tag PA-RVA5-3205 to 3199, Fig. S6 ) is homologous (48-72% similar at the amino acid level) to the type-VI like evp operon involved in virulence in the fish pathogen Edwardsiella tarda (19, 20) .
Functional Annotation of Secondary Metabolite Gene Clusters. It is notoriously difficult to ascribe biological function to gene clusters responsible for the synthesis of secondary metabolites such as polyketide synthesis (PKS) and non-ribosomal peptide synthesis (NRPS) enzyme complexes. Like many pathogens, Photorhabdus dedicates a large amount of coding sequence to the manufacture of small molecules but their biological roles and structures remain unknown. RVA identified a number of regions predicted to encode NRPS/PKS-like complexes and Fig. 3A illustrates four examples of identified cosmids that exhibit a range of activities including the ability of the recombinant E. coli to kill G. mellonella upon injection (Fig. 3B) . HPLC/MS analysis of preparations from cosmids 4DB5 (RVA5) and 1DF9 (RVA14) identified 265.4/468.4 and 586.4 as specific [MϩH] ϩ masses for the respective molecules, which were not present in the E. coli control (Fig. S24) . Two compounds were identified from cosmid 4DB5 (RVA5) encoding a gene cluster with high similarity to the yersiniabactin biosynthesis genes. The postulated sum formula C 12 H 12 ON 2 S 2 is identical to the sum formula of ulbactin E, a short derivative of yersiniabactin, which has been described from a marine Alteromonas strain (21) . The second compound C 20 H 25 O 4 N 3 S 3 might represent a desmethylderivative of yersiniabactin (C 21 H 27 O 4 N 3 S 3 ) that has not been described in the literature yet. The identified sum formula of C 32 H 51 O 5 N 5 , from 1DF9 cosmid (RVA14), fits well with the structure of a cyclic pentapeptide. Interestingly, an identical sum formula is found in sansalvamide A peptides (22) (23) (24) , synthetic derivatives of the depsipeptide natural product sansalvamide A that were isolated from a marine fungus and showed potent anti-cancer activity (25) . Isolation of all identified compounds for detailed structure elucidation is currently underway. Preliminary structural predictions of other secondary metabolites identified by RVA are presented in Table S1 . One example is the predicted compound encoded by RVA 18 (Fig. S19 ) similar to a new antitumor antibiotic: glidobactin from Polyangium brachysporum (26) . Two PKS clusters and one NRPS gene cluster were also encoded in mGOT RVA regions, suggesting that secondary metabolites produced from these operons could have potential roles in human pathogenicity. The rapid identification of new biological activities from these secondary metabolite synthetic genes suggests that RVA analysis can be a powerful method of drug discovery. Identification of Virulence Gene Clusters. Our recent work on secretion of the orally active Toxin Complex d (Tcd) from P. luminescens indicates that a putative class III lipase pdl (27) is responsible for release of Tcd from the outer membrane of the bacterium and that this process is negatively regulated by the tightly linked gene orf54 (G. Yang and N.R.W., unpublished work). We detected several regions encoding pdl-o54 gene homologues in the P. asymbiotica genome that were toxic to either insects and/or nematodes. We therefore speculate that these represent virulence loci (Fig. 4A, and Figs. S7 and S20). We note that these regions have no effect on the mammalian macrophages again suggesting some specificity in their toxicity. Interestingly, pdl-islands are also present in the genomes of many other Gram-negative pathogens, including Vibrio cholerae, suggesting they also may be virulence determinants in other human pathogens. In characterizing RVA regions such as these, determination of the minimal region of overlap between ''toxic'' cosmids at any given locus may not provide sufficient clues to suggest the exact genes responsible. Thus, we carried out insertional mutagenesis to map the genes causing the phenotype by using an in vitro mutagenesis kit to construct insertion mutant libraries of toxic cosmids. Clones with insertions in different genes are then identified by sequencing out from the integrated transposon. The mutated cosmids are rescreened in the appropriate RVA assay to identify clones showing loss of function and therefore the ORF responsible. In the case of the Pa pdl1-GI2 insecticidal region, we selected the 4DE10 toxic cosmid for this fine-scale mapping (Fig. 4B ). This identified vgrG and two of the pdl-homologues as necessary for the toxic effect on G. mellonella. Subcloning and heterologous expression of vgrG in E. coli (Fig.   4C ) confirmed the toxicity of this gene product and serves to illustrate how RVA allows us to move from a whole genome to an individual toxin gene with ease. Importantly, the RVA approach is also powerful in identifying genes with functions that could not be predicted using conventional genetic approaches. Three cosmids were identified in the iGOT screen, 3CD1, 3DB8, and 1AA3 (RVA17, Fig. S18 ), causing a moribund phenotype when injected to M. sexta. Fine-scale mapping traced the toxic effect to kdpEDCBAF encoding the high affinity potassium pump (28) of P. asymbiotica (Fig. S25) . Over-expression of the Kdp pump appears to allow the bacteria to persist and even grow in the hemocytes (I. Vlisidou and N.R.W., unpublished work). This striking fundamental discovery is likely to be relevant to all immune cell-pathogen interactions, which rely upon high potassium gradients for maturation of the phagolysosome (29) . We propose that the assumption-free RVA screening technology is ideal for making such discoveries and expect many more from a range of pathogens.
Virulence Against Insect or Man? It was anticipated that in the case of P. asymbiotica, a comparison between the invertebrate and macrophage (mGOT) RVA data could provide candidate genes responsible for facilitating human infection. Cosmids in RVA4 were identified by the mGOT screen but not in either of the invertebrate assays. This region does not encode genes unique to the human pathogenic P. asymbiotica and, therefore, has homologues in the insect-only pathogen P. luminescens TT01. RVA4 (Fig. S5) contains homologues of the proapoptotic xaxAB from Xenorhabdus (30) and a large hemolysin/hemagglutinin gene, either of which may represent potential virulence factors. Interestingly, the majority of mGOT regions are also shown to have effects in invertebrate hosts, supporting our hypothesis that genes evolved to combat invertebrates can be redeployed against mammalian hosts (3).
Discussion
Here, we have demonstrated the ability of RVA to identify virulence loci via the parallel screening of a recombinant DNA library in a non-pathogenic laboratory strain of E. coli against a range of different taxa. The RVA analysis of P. asymbiotica identified a range of different putative virulence factors including eight NRPS operons, two PKS operons, six hemolysin/ hemagglutinin-like genes, three pili/fimbrial operons, seven putative specialized secretion systems (PVCpnf, T6SS, Evp-islands, T3SS and Pld-islands) and at least seven toxin-like genes (homologues of mcf1, xaxAB, vgrG, rtxA, xnt2, ast, and a VIP2 family gene). The identification of such a large number of virulence loci illustrates that RVA is useful as a means of generating preliminary biological annotation relating to pathogenic phenotypes. RVA annotation highlights operons or genes as potentially important in virulence that can then be investigated in greater detail either for accurate annotation or more specific applications (i.e., drug discovery or vaccine candidates). Therefore, fine-scale mapping of RVA regions, by transposon mutagenesis or cloning individual ORFs, is essential to confirm the exact genes responsible for toxicity in each cluster. The use of different invertebrate targets with less complex immune responses (insects, nematodes, and protozoa) allows the detection of less ''potent'' virulence factors that could otherwise be overlooked in whole animal mammalian models. It is interesting that most of the virulence factors identified in the mGOT assay were also toxic in the invertebrate screens confirming the general utility of invertebrates as model hosts for disease studies. Although it is likely that a small subset of host-specific virulence factors will not be detected by RVA, the screens are nevertheless sensitive enough to detect a very large number of more numerous general virulence factors.
The power of the RVA technique relies on several factors. First and highly important is the coverage and the depth of the genomic library used that covered Ͼ90% of the genome, with nearly 80% being covered by two or more clones. The analysis of the cosmid library distribution on the genome assembly confirmed that some regions are more represented than others and certain regions are absent. In future RVA studies it may be pertinent to ''normalize'' the library by selecting a subset of cosmids for the assays, reducing the level of redundancy in testing while still maximizing genome coverage. The second factor is the underlying genetic architecture of virulence factors. RVA's strength is in the identification of single-loci virulence factors and multilocus virulence factors that are tightly clustered within a bacterial genome. Molecular characterization of virulence factors to date suggests that the majority fall into these categories, further justifying our screening approach. However, there are several notable examples of virulence factors for which the underlying genetics basis is complex and involves multiple genes or regions of the genome, and these will naturally not be identified by RVA. This limitation can be overcome by using vectors that accommodate larger fragments such as BACs. Frequent concerns regarding heterologous expression in E. coli include potential problems in differing GϩC content between host and donor DNA and a failure of E. coli expression machinery either to recognize the donor gene expression signals or to provide the appropriate secretion machinery. Nevertheless, the successful application of RVA to Photorhabdus, with an average GϩC content of 42%, significantly lower than the 50% of E. coli, indicates that this is not a current limitation to these biological screens. One reason why E. coli-based expression is more successful than expected may relate to the fact that pathogenicity islands that have been recently horizontally acquired may be more prone to gene expression in differing host backgrounds, and indeed this may actually be a requirement of such elements if they are to be positively selected in nature. Furthermore, the RVA technique does not only rely on correct secretion of the heterologously expressed virulence factors as whole cultures are used in the screens. We note that cytoplasmically accumulated toxins can be detected in these assays, as demonstrated by the insect toxicity of E. coli expressing but not secreting the Mcf1 toxin (14) . The application of RVA to more diverse bacterial pathogens will ultimately define the limits of its utility, although in principle the host strain used need not be E. coli and libraries from Gram-positive pathogens could be screened in different host species (such as Lactococcus).
We believe that RVA represents an excellent way to provide basic information about general virulence determinants in poorly understood pathogens and to add functional relevance to the ongoing annotation of pathogen genome sequences. It also provides an alternative strategy for virulence gene detection across whole genomes, important for current efforts toward the reduction and replacement of animal testing.
Materials and Methods
Cosmid Library Construction and Statistical Analysis. The P. asymbiotica ATCC43949 genomic library was constructed in the pWEB vector (Epicentre) in E. coli EP1305 TM by MWG Biotech. The 1,536 resulting cosmids were arrayed into 16 96-well plates and end-sequenced before storage at Ϫ80°C. Cosmid size and location were determined by BLASTN comparison of each end against the unfinished genome. Average cosmid length is 37,014 bp (SD ϭ 4578.4) and 4,605,359 bp is covered representing 91.4% of the estimated 5.0 Mb genome.
